NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023...
Buyer
NHS England
Value
£27,009,807
Published
27 Apr 2023
Closes
21 Feb 2023
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
30 Apr 2023
Contract ends
31 Jan 2025
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection
£27,009,807
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion)...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
27 Apr 2023
Awarded contract notice on Contracts Finder
Award notice · Web page
CM_PHG_22_5694_00 Transparency Award Schedules
Not provided
CM_PHG_22_5694_00 Transparency Award Schedules
CM_PHG_22_5694_01 Transparency Award Schedule
Not provided
CM_PHG_22_5694_01 Transparency Award Schedule
Contains public sector information licensed under the Open Government Licence v3.0.